Prognostic value of CD44 splice variants in human stage III cervical cancer

This publication has 9 references indexed in Scilit:

• Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma
  British Journal of Cancer, 1993
• Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.
  The Journal of Experimental Medicine, 1993
• Significance of CD44 gene products for cancer diagnosis and disease evaluation
  The Lancet, 1992
• A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.
  Journal of Clinical Oncology, 1991
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
  Cell, 1991
• ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSION
  Annual Review of Genetics, 1989
• Pelvic lymph node metastasis of uterine cervical cancer
  Gynecologic Oncology, 1987
• Prognostic factors and operative treatment of Stages IB to IIB cervical cancer
  American Journal of Obstetrics and Gynecology, 1987
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958